Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice. ✅
Go to Publication ✅
Redox biology (Redox Biol ) Vol: 57 Issue Pages: 102481 Pub: 2022 Sep 15 Epub: 2022 Sep 15 Authors Zhang Y , Cheng Y , Liu J , Zuo J , Yan L , Thring RW , Ba X , Qi D , Wu M , Gao Y , Tong H , |
|
|
Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice. ✅
Go to Publication ✅
Redox biology (Redox Biol ) Vol: 57 Issue Pages: 102481 Pub: 2022 Sep 15 Epub: 2022 Sep 15 Authors Zhang Y , Cheng Y , Liu J , Zuo J , Yan L , Thring RW , Ba X , Qi D , Wu M , Gao Y , Tong H , |
|
|
Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis. ✅
Go to Publication ✅
Infection and immunity (Infect Immun ) Vol: 90 Issue 8 Pages: e0015322 Pub: 2022 Aug 18 Epub: 2022 Jul 7 Authors Pike CM , Tam J , Melnyk RA , Theriot CM , |
|
|
Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 16684 Pub: 2021 Aug 17 Epub: 2021 Aug 17 Authors Bravard A , Gérard C , Defois C , Benoit B , Makki K , Meugnier E , Rainteau D , Rieusset J , Godet M , Vidal H , |
|
|
Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes. ✅
Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 48 Issue 9 Pages: 300060520936806 Pub: 2020 Sep Epub: Authors Wang Y , Ye X , Ding D , Lu Y , |
|
|
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. ✅
Go to Publication ✅
British journal of pharmacology (Br J Pharmacol ) Vol: 175 Issue 3 Pages: 469-484 Pub: 2018 Feb Epub: 2018 Jan 3 Authors Wang W , Zhao J , Gui W , Sun D , Dai H , Xiao L , Chu H , Du F , Zhu Q , Schnabl B , Huang K , Yang L , Hou X , |
|
|
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. ✅
Go to Publication ✅
British journal of pharmacology (Br J Pharmacol ) Vol: 175 Issue 3 Pages: 469-484 Pub: 2018 Feb Epub: 2018 Jan 3 Authors Wang W , Zhao J , Gui W , Sun D , Dai H , Xiao L , Chu H , Du F , Zhu Q , Schnabl B , Huang K , Yang L , Hou X , |
|
|
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 83 Issue 7 Pages: Pub: 2017 Apr 1 Epub: 2017 Mar 17 Authors Van den Bossche L , Hindryckx P , Devisscher L , Devriese S , Van Welden S , Holvoet T , Vilchez-Vargas R , Vital M , Pieper DH , Vanden Bussche J , Vanhaecke L , Van de Wiele T , De Vos M , Laukens D , |
|
|
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 83 Issue 7 Pages: Pub: 2017 Apr 1 Epub: 2017 Mar 17 Authors Van den Bossche L , Hindryckx P , Devisscher L , Devriese S , Van Welden S , Holvoet T , Vilchez-Vargas R , Vital M , Pieper DH , Vanden Bussche J , Vanhaecke L , Van de Wiele T , De Vos M , Laukens D , |
|
|
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 83 Issue 7 Pages: Pub: 2017 Apr 1 Epub: 2017 Mar 17 Authors Van den Bossche L , Hindryckx P , Devisscher L , Devriese S , Van Welden S , Holvoet T , Vilchez-Vargas R , Vital M , Pieper DH , Vanden Bussche J , Vanhaecke L , Van de Wiele T , De Vos M , Laukens D , |
|
|
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation. ✅
Go to Publication ✅
Annals of hepatology (Ann Hepatol ) Vol: 23 Issue Pages: 100289 Pub: 2021 Jul-Aug Epub: 2020 Nov 18 Authors Lu Q , Jiang Z , Wang Q , Hu H , Zhao G , |
|
|
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation. ✅
Go to Publication ✅
Annals of hepatology (Ann Hepatol ) Vol: 23 Issue Pages: 100289 Pub: 2021 Jul-Aug Epub: 2020 Nov 18 Authors Lu Q , Jiang Z , Wang Q , Hu H , Zhao G , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
